找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: 31st Hemophilia Symposium; Hamburg 2000 Inge Scharrer,Wolfgang Schramm Conference proceedings 2002 Springer-Verlag Berlin Heidelberg 2002 H

[復(fù)制鏈接]
樓主: Harrison
41#
發(fā)表于 2025-3-28 15:45:53 | 只看該作者
42#
發(fā)表于 2025-3-28 20:38:28 | 只看該作者
The Jewish Refugee Community in Shanghaivalence of diseases. The early questionnaires used in the survey focused on basic data and were later expanded by additional information particularly about HIV infection and AIDS-related death. Since 1998 more specific data on hepatitis and antiretroviral therapies have been included. Future surveys
43#
發(fā)表于 2025-3-28 23:06:48 | 只看該作者
A Turning Point: The Past and the Future,tor VIII concentrates or recombinant factor VIII. Up to 25% of patients may develop antibodies against FVIII (FVIII:Ab). Antibodies arise more often in patients with severe form of hemophilia A caused by inversion, large deletion or stop codon in FVIII gene rather than in patients with mild or moder
44#
發(fā)表于 2025-3-29 03:04:14 | 只看該作者
A Turning Point: The Past and the Future,fesaving treatment as well as inhibitor eradication therapy leading to a cure of this disease (2, 5, 6, 7, 11, 12, 13). In April 1996 we combined elements from the Malm? and Bonn protocols, which were mainly developed for the eradication of inhibitors in patients with congenital hemophilia, to creat
45#
發(fā)表于 2025-3-29 11:17:24 | 只看該作者
https://doi.org/10.1007/978-981-99-6819-0cs, medication and operative procedure. As a consequence, defects in plasmatic as well as in cellular components of the coagulation system can result in severe bleeding complications. Due to the diverse nature of hemostasis disorders and the variety of therapeutic options, a targeted therapeutic man
46#
發(fā)表于 2025-3-29 13:21:10 | 只看該作者
47#
發(fā)表于 2025-3-29 15:42:38 | 只看該作者
48#
發(fā)表于 2025-3-29 22:27:52 | 只看該作者
49#
發(fā)表于 2025-3-30 02:00:05 | 只看該作者
50#
發(fā)表于 2025-3-30 08:06:40 | 只看該作者
The Language Situation in Macao,tion of thrombin generation has been shown to be able to distinguish between different forms of hyper- and hypocoagulability (7). The observed increased thrombin generation in the presence of FEIBA might be connected with sporadically documented thrombotic complications after its administration (4).
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 14:01
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
谢通门县| 工布江达县| 萍乡市| 民县| 万盛区| 临夏市| 南昌市| 十堰市| 林芝县| 萨嘎县| 嘉禾县| 龙泉市| 汤原县| 绥化市| 张掖市| 墨脱县| 牡丹江市| 柘荣县| 海城市| 台山市| 潍坊市| 五台县| 雅安市| 怀仁县| 乐昌市| 鄂托克前旗| 黄石市| 乐安县| 额敏县| 广饶县| 丰宁| 桦川县| 南木林县| 灵丘县| 仙游县| 上林县| 民县| 上杭县| 靖江市| 尤溪县| 明水县|